Clinical Integration of Artificial Intelligence in Urology with a Focus on Temporal Deep Neural Networks for Emphysematous Pyelonephritis

Artificial intelligence (AI) is transforming urology by facilitating quick, data-driven analysis in diagnosis and treatment. This chapter explores core AI concepts and their applications in urological conditions like kidney stones, bladder cancer, prostate cancer, and benign prostatic hyperplasia (BPH). Examples of models (such as convolutional neural networks and support vector machines) used in urology are used to teach general AI approaches (machine learning and deep learning). Automated MRI prostate cancer diagnosis (AUC ~0.96), ureteroscopic stone identification (CNN ~90% accuracy), and bladder tumour segmentation are significant achievements. Additionally, the chapter highlights issues with dataset heterogeneity, sample size, and selection bias while briefly discussing the types of datasets used in AI-driven urology research, including imaging, clinical, and longitudinal data. A case study of an emerging multi-task deep neural network (t-MTDNN) for the prediction of emphysematous pyelonephritis (EPN) is included. Feature descriptions (SHAP) are provided for the t-MTDNN architecture and workflow, and its clinical impact and performance metrics are analysed. In conclusion, the strengths and challenges of AI models are compared (Table 1) and prospective opportunities in AI-assisted urology are described with an emphasis on the therapeutic advantages (improved accuracy, efficiency) and limitations (data requirements, interpretability). Instead of replacing clinical judgement, urologists and healthcare organisations view AI as a clinical decision-support tool that can enhance workflow efficiency, support hospital-level adoption through interdisciplinary collaboration, and augment physician expertise.